NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
NBD delivery improves the disease phenotype of the golden retriever model of Duchenne muscular dystrophy
Authors
Keywords
Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy, Duchenne Muscular Dystrophy Patient, Heterogeneity Index, Golden Retriever With Muscular Dystrophy
Journal
Skeletal Muscle
Volume 4, Issue 1, Pages 18
Publisher
Springer Nature
Online
2014-10-23
DOI
10.1186/2044-5040-4-18
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase I Clinical Trial of Systemically Delivered NEMO Binding Domain Peptide in Dogs with Spontaneous Activated B-Cell like Diffuse Large B-Cell Lymphoma
- (2014) Georges Habineza Ndikuyeze et al. PLoS One
- Pharmacological prospects in the treatment of Duchenne muscular dystrophy
- (2013) Urs T. Ruegg CURRENT OPINION IN NEUROLOGY
- Anaphylaxis in dogs and cats
- (2013) Daniella L. Shmuel et al. JOURNAL OF VETERINARY EMERGENCY AND CRITICAL CARE
- Characteristics of magnetic resonance imaging biomarkers in a natural history study of golden retriever muscular dystrophy
- (2013) Zheng Fan et al. NEUROMUSCULAR DISORDERS
- A computerized MRI biomarker quantification scheme for a canine model of Duchenne muscular dystrophy
- (2013) Jiahui Wang et al. International Journal of Computer Assisted Radiology and Surgery
- Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies
- (2012) Joe N. Kornegay et al. MAMMALIAN GENOME
- Gene and cell-mediated therapies for muscular dystrophy
- (2012) Patryk Konieczny et al. MUSCLE & NERVE
- Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy
- (2011) Dawn A Delfín et al. Journal of Translational Medicine
- NF-κB Negatively Impacts the Myogenic Potential of Muscle-derived Stem Cells
- (2011) Aiping Lu et al. MOLECULAR THERAPY
- Systemic delivery of NEMO binding domain/IKKγ inhibitory peptide to young mdx mice improves dystrophic skeletal muscle histopathology
- (2011) Daniel P. Reay et al. NEUROBIOLOGY OF DISEASE
- Inhibition of the IKK/NF-κB pathway by AAV gene transfer improves muscle regeneration in older mdx mice
- (2010) Y Tang et al. GENE THERAPY
- Change in Natural History of Duchenne Muscular Dystrophy With Long-term Corticosteroid Treatment: Implications for Management
- (2010) Richard T. Moxley et al. JOURNAL OF CHILD NEUROLOGY
- Eccentric contractions induce rapid isometric torque drop in dystrophin-deficient dogs
- (2010) Christopher J. Tegeler et al. MUSCLE & NERVE
- Biglycan recruits utrophin to the sarcolemma and counters dystrophic pathology in mdx mice
- (2010) A. R. Amenta et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of systemic morpholino exon-skipping in duchenne dystrophy dogs
- (2009) Toshifumi Yokota et al. ANNALS OF NEUROLOGY
- Diagnosis and new treatments in muscular dystrophies
- (2009) A Y Manzur et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Evaluation of dystrophic dog pathology by fat-suppressed T2-weighted imaging
- (2009) Masanori Kobayashi et al. MUSCLE & NERVE
- l-Arginine Decreases Inflammation and Modulates the Nuclear Factor-κB/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers
- (2008) Karim Hnia et al. AMERICAN JOURNAL OF PATHOLOGY
- Two-tiered hypotheses for Duchenne muscular dystrophy
- (2008) M. D. Grounds CELLULAR AND MOLECULAR LIFE SCIENCES
- Treatment with inhibitors of the NF-κB pathway improves whole body tension development in the mdx mouse
- (2008) Ashley L. Siegel et al. NEUROMUSCULAR DISORDERS
- Structure of a NEMO/IKK-Associating Domain Reveals Architecture of the Interaction Site
- (2008) Mia Rushe et al. STRUCTURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started